Paragraph: The coronary artery bypass grafting market involves medical procedures that use grafts to bypass coronary arteries and improve blood flow to the heart. In CABG surgery, a blood vessel graft is used to reroute blood flow around blocked or narrowed coronary arteries and improve the supply of blood and oxygen to the heart. It is used to treat severe coronary artery disease when medications and other treatments have failed. The market comprises products such as guidewires, balloon pumps, cannulae, cardiac catheters, and grafts like artery and vein grafts. These products are used in traditional CABG and off-pump CABG procedures to improve cardiac function in patients. The need for effective treatments of cardiovascular diseases and increasing risk factors globally are major drivers for the coronary artery bypass grafting market.

Global Coronary Artery Bypass Grafting Market is estimated to be valued at US$ 14.02 Bn in 2024 and is expected to exhibit a CAGR of 9.5% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the Coronary Artery Bypass Grafting are Abbott Laboratories, Medtronic, Boston Scientific Corporation, LivaNova PLC, Edwards Lifesciences Corporation, Maquet Holding B.V. & Co. KG, TERUMO CORPORATION, Guidant, Vitalitec, Novadaq, KARL STORZ, Ethicon US, LLC (Johnson & Johnson), NeoGraft Technologies, Inc., Genesee Biomedical Inc., Hancock Jaffe Laboratories, Inc., VasoPrep Surgical, Dextera Surgical Inc., and Neograft Inc. The key players are focused on new product launches and advances in grafting technologies to strengthen their market position.

The Coronary Artery Bypass Grafting Market Demand like CABG. According to the WHO, cardiovascular diseases are the largest cause of deaths globally, taking an estimated 17.9 million lives each year. Rising risk factors like obesity, smoking, and unhealthy lifestyle have contributed to the increasing prevalence of coronary artery disease.

With growing awareness and availability of advanced treatment options, the CABG market is expanding globally. Countries in the Asia Pacific and Latin America are witnessing higher adoption rates due to growing medical infrastructure and healthcare expenditures. The demand for CABG procedures is expected to increase the most in rapidly developing economies.

Get More Insights On, Coronary Artery Bypass Grafting Market